Volitionrx Ltd (VNRX)

Jan 8, 2025, 8:30 AM EST - 9 days ago

Volition Issues Business Review 2024

Dec 12, 2024, 8:00 AM EST - 5 weeks ago

VolitionRx Appoints LifeSci Advisors as Investor Relations Consultants

Dec 10, 2024, 8:00 AM EST - 5 weeks ago

Study shows Nu.Q® Lung Cancer Test differentiated malignant and benign nodules found by Low Dose CT screening

Dec 6, 2024, 9:00 AM EST - 6 weeks ago

VolitionRx Announces Pricing of up to $1.9 Million Registered Direct Offering

Nov 15, 2024, 11:47 AM EST - 2 months ago

VolitionRx Limited (VNRX) Q3 2024 Earnings Call Transcript

Nov 14, 2024, 4:10 PM EST - 2 months ago

VolitionRx Limited Announces Third Quarter 2024 Financial Results and Business Update

Nov 8, 2024, 8:00 AM EST - 2 months ago

VolitionRx Limited Schedules Third Quarter 2024 Earnings Conference Call and Business Update

Nov 6, 2024, 4:10 PM EST - 2 months ago

Volition Appoints Timothy I. Still as Chairman

Oct 31, 2024, 8:00 AM EDT - 2 months ago

Multiple studies show Nu.Q® NETs test could predict sepsis patients at risk of deteriorating

Oct 9, 2024, 8:00 AM EDT - 3 months ago

Volition to share new 'NETs in sepsis management' data insights at upcoming webinar

Oct 3, 2024, 8:00 AM EDT - 3 months ago

Volition hosts NETs in sepsis management symposium at ESICM Lives 2024

Sep 30, 2024, 4:10 PM EDT - 3 months ago

Volition Appoints Dr. Ethel Rubin as an Independent Director

Sep 11, 2024, 8:00 AM EDT - 4 months ago

Volition Hosts KOL Roundtable on Sepsis

Aug 15, 2024, 12:11 PM EDT - 5 months ago

VolitionRx Limited (VNRX) Q2 2024 Earnings Call Transcript

Aug 14, 2024, 4:10 PM EDT - 5 months ago

VolitionRx Limited Announces Second Quarter 2024 Financial Results and Business Update

Aug 9, 2024, 8:00 AM EDT - 5 months ago

VolitionRx Announces Pricing of up to $21.5 Million Registered Direct Offering

Aug 6, 2024, 8:00 AM EDT - 5 months ago

VolitionRx Limited Schedules Second Quarter 2024 Earnings Conference Call and Business Update

Jul 9, 2024, 8:30 AM EDT - 6 months ago

Volition appoints PharmaVentures for Capture PCR™ and oncology portfolio licensing

Jun 27, 2024, 8:00 AM EDT - 7 months ago

VolitionRx Limited Issues Mid-Year Review Ahead of 2024 Annual Meeting

Jun 14, 2024, 9:00 AM EDT - 7 months ago

Nexalin Technology and VolitionRX Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV

NXL

May 29, 2024, 8:00 AM EDT - 8 months ago

VolitionRx Limited to Present at Jefferies Global Healthcare Conference

May 14, 2024, 8:24 PM EDT - 8 months ago

VolitionRx Limited (VNRX) Q1 2024 Earnings Call Transcript

May 13, 2024, 4:10 PM EDT - 8 months ago

VolitionRx Limited Announces First Quarter 2024 Financial Results and Business Update

May 8, 2024, 8:00 AM EDT - 9 months ago

VolitionRx Limited Schedules First Quarter 2024 Earnings Conference Call and Business Update

Apr 23, 2024, 8:00 AM EDT - 9 months ago

Nu.Q® Vet Cancer Test launched in-clinic in U.S. and Europe through Antech

Mar 26, 2024, 12:43 PM EDT - 10 months ago

VolitionRx Limited (VNRX) Q4 2023 Earnings Call Transcript

Mar 25, 2024, 4:10 PM EDT - 10 months ago

VolitionRx Limited Announces Full Fiscal Year 2023 Financial Results and Business Update

Mar 21, 2024, 8:30 AM EDT - 10 months ago

VolitionRx Limited Schedules Fourth Quarter and Full Year 2023 Earnings Conference Call and Business Update

Mar 20, 2024, 8:30 AM EDT - 10 months ago

Volition and Fujifilm Vet Systems Launch Nu.Q® Vet Cancer Test in Japan

Mar 19, 2024, 4:30 PM EDT - 10 months ago

Volition appoints Dr Andrew Retter as Chief Medical Officer

Feb 2, 2024, 8:00 AM EST - 1 year ago

Volition to Share Nu.Q® NETs Strategy Update at Upcoming Webinar

Jan 4, 2024, 8:00 AM EST - 1 year ago

Volition Issues Business Review 2023

Dec 5, 2023, 8:00 AM EST - 1 year ago

VolitionRx Secures Approximately $5.5 Million in Belgium Regional Government Financing from Wallonie Entreprendre

Nov 15, 2023, 3:41 PM EST - 1 year ago

VolitionRx Limited (VNRX) Q3 2023 Earnings Call Transcript

Nov 14, 2023, 4:10 PM EST - 1 year ago

VolitionRx Limited Announces Third Quarter 2023 Financial Results and Business Update

Nov 8, 2023, 8:00 AM EST - 1 year ago

VolitionRx Limited Schedules Third Quarter 2023 Earnings Conference Call and Business Update

Nov 6, 2023, 6:21 AM EST - 1 year ago

Volition and VPG Launch Nu.Q® Vet Cancer Test in UK & Ireland

Oct 23, 2023, 8:00 AM EDT - 1 year ago

Volition Presents Breakthrough Liquid Biopsy Blood Test Method for Early-stage Cancer

Oct 19, 2023, 8:00 AM EDT - 1 year ago

Measuring Nucleosomes Using Nu.Q® NETs is a Promising Biomarker for Septic Shock

Oct 18, 2023, 12:00 PM EDT - 1 year ago

US Ambassador Adler visits Belgian Volition

Oct 16, 2023, 8:00 AM EDT - 1 year ago

Volition Presents Three Cancer Detection Abstracts at ESMO 2023

Oct 13, 2023, 8:00 AM EDT - 1 year ago

Volition Publishes Key Opinion Leader Roundtable Report on NETs in Sepsis

Oct 6, 2023, 8:26 AM EDT - 1 year ago

Top 4 Health Care Stocks That Are Preparing To Pump This Quarter - Omega Therapeutics (NASDAQ:OMGA), Cutera (NASDAQ:CUTR)

CUTR OMGA RVMD

Oct 2, 2023, 8:00 AM EDT - 1 year ago

Volition to Reveal New Cancer Detection Method Insights at Upcoming Webinar

Sep 13, 2023, 8:00 AM EDT - 1 year ago

Volition Hosts Key Opinion Leader Roundtable on Sepsis Management

Aug 15, 2023, 12:27 PM EDT - 1 year ago

VolitionRx Limited (VNRX) Q2 2023 Earnings Call Transcript

Aug 14, 2023, 4:10 PM EDT - 1 year ago

VolitionRx Limited Announces Second Quarter 2023 Financial Results and Business Update

Aug 9, 2023, 8:00 AM EDT - 1 year ago

VolitionRx Limited Schedules Second Quarter 2023 Earnings Conference Call and Business Update

Jun 23, 2023, 4:10 PM EDT - 1 year ago

VolitionRx Limited Announces Exercise of Over-Allotment Option by Underwriters

Jun 5, 2023, 4:10 PM EDT - 1 year ago

VolitionRx Limited Announces Closing of $16.5 Million Underwritten Public Offering of Common Stock